Literature DB >> 529018

Pharmacokinetics of clonidine in the rat and cat.

L K Paalzow, P O Edlund.   

Abstract

To investigate the pharmacokinetic behavior of clonidine, rats were given clonidine intravenously at 125, 250, and 500 micrograms/kg and blood clonidine concentrations were followed for 6 hr. The disposition of clonidine in two brain regions was studied in rats after an i.v. dose of 500 micrograms/kg. The liver clearance in rats was investigated by liver perfusion techniques. The results obtained indicate that the disposition characteristics of clonidine can be described by a two-compartment open model in both rats and cats. The penetration of clonidine into tissues is rapid, and brain levels in rats were about 1.7 times higher than blood levels. Brain tissues were found to be an indistinguisible part of the central (blood) compartment. Dose-dependent pharmacokinetic behavior was found for clonidine in rats at the doses used. This was demonstrated by a decrease of both the rate constant of distribution to the peripheral compartment and the overall elimination rate constant from the body, with increase in dose. As a consequence, the volume of distribution and the clearance both decreased with increasing dose. Possible explanations for the dose-dependent behavior of clonidine are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 529018     DOI: 10.1007/BF01062390

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  26 in total

1.  Metabolism of morphine in the perfused rat liver.

Authors:  B E Dahlström; J Jonsson; L K Paalzow
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976-07

2.  Sedative effects of alpha-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs.

Authors:  B Delbarre; H Schmitt
Journal:  Eur J Pharmacol       Date:  1971       Impact factor: 4.432

3.  Antinociceptive effects of some alpha-sympathomimetic agents.

Authors:  H Schmitt; J C Le Douarec; N Petillot
Journal:  Neuropharmacology       Date:  1974-05       Impact factor: 5.250

4.  Further similarities between the action of clonidine and a central activation of the depressor baroreceptor reflex.

Authors:  G Haeusler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  Acute hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery.

Authors:  R W Sattler; P A van Zwieten
Journal:  Eur J Pharmacol       Date:  1967-10       Impact factor: 4.432

6.  Effect of clonidine on blood pressure, heart rate and body temperature in conscious rats.

Authors:  H Ozawa; C S Chen; H Watanabe; T Uematsu
Journal:  Jpn J Pharmacol       Date:  1977-02

7.  Quantitative gas-liquid chromatographic determination of clonidine in plasma.

Authors:  P O Edlumd; L K Paalzow
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-01

8.  The physiological disposition of 2(2,6-dichloroanilino)-2-imidazoline (St-155).

Authors:  A K Cho; S H Curry
Journal:  Biochem Pharmacol       Date:  1969-02       Impact factor: 5.858

9.  Gluconeogenesis in the perfused rat liver.

Authors:  R Hems; B D Ross; M N Berry; H A Krebs
Journal:  Biochem J       Date:  1966-11       Impact factor: 3.857

10.  Clonidine antinociceptive activity: effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat.

Authors:  G Paalzow; L Paalzow
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

View more
  7 in total

1.  Multiple receptor responses: a new concept to describe the relationship between pharmacological effects and pharmacokinetics of a drug: studies on clonidine in the rat and cat.

Authors:  L K Paalzow; P O Edlund
Journal:  J Pharmacokinet Biopharm       Date:  1979-10

2.  Tissue pharmacokinetics of clonidine in rats.

Authors:  E L Conway; B Jarrott
Journal:  J Pharmacokinet Biopharm       Date:  1982-04

3.  Carrier-mediated uptake of clonidine in cultured human lung cells.

Authors:  Marc Le Vée; Elodie Jouan; Olivier Fardel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-01-19       Impact factor: 3.000

4.  Clonidine and Brain Mitochondrial Energy Metabolism: Pharmacodynamic Insights Beyond Receptorial Effects.

Authors:  Roberto Federico Villa; Antonella Gorini; Federica Ferrari
Journal:  Neurochem Res       Date:  2022-01-31       Impact factor: 3.996

5.  Clonidine kinetics in man--evidence for dose dependency and changed pharmacokinetics during chronic therapy.

Authors:  M Frisk-Holmberg; L Paalzow; P O Edlund
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

6.  Relationship between the cardiovascular effects and steady-state kinetics of clonidine in hypertension. Demonstration of a therapeutic window in man.

Authors:  M Frisk-Holmberg; L Paalzow; L Wibell
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Increase in insulin response to glucose in the rat chronically treated with clonidine.

Authors:  K Ishii; S Yamamoto; R Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.